trial · primary record
Sitagliptin/metformin hydrochloride tablets (50 mg/850 mg)
Healhty
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 56 |
| Primary completion | 2025-03-26 |
| Primary endpoint | Cmax of sitagliptin |
| Registry ID | NCT07910682 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:39.013Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07910682
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.